Keeping Track: Approval Of First Intranasal Naloxone Copycat Highlights Otherwise Generic Week
Executive Summary
The latest drug development news and highlights from our US FDA Performance Tracker.
You may also be interested in...
Purdue's Opioid Rescue Drug Development To Continue Under A New Company
Purdue proposes continuing the development of nalmefene hydrochloride and other products under a new company that would provide the products at no or low cost.
Keeping Track: CDER Ties Monthly Novel Approval Record With Nourianz Green Light
The latest drug development news and highlights from our US FDA Performance Tracker.
US FDA Asks Sponsors Of Discontinued Naloxones To Consider Return To Market
In announcing expedited assessments for new naloxone ANDAs, the agency also offers guidance to sponsors of discontinued products considering a return to marketing.